Greatbatch to draw on revolver for Precimed purchase

By Sara Rosenberg

New York, Nov. 26 - Greatbatch Inc. plans to use borrowings under its revolving credit facility, along with cash on hand, to fund the about $125 million acquisition of Precimed, according to a news release.

The transaction is expected to close in early 2008.

Greatbatch is a Clarence, N.Y.-based developer and manufacturer of critical components used in medical devices for the cardiac rhythm management, neurostimulation, vascular and interventional radiology markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.